CytoMed Therapeutics Limited (NASDAQ: GDTC)
$2.4100
+0.0400 ( -1.94% ) 4.1K
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
Market Data
Open
$2.4100
Previous close
$2.3700
Volume
4.1K
Market cap
$29.54M
Day range
$2.4000 - $2.5250
52 week range
$1.2000 - $5.5000
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
6-k | Form 6-K | 1 | Dec 05, 2024 |
6-k | Form 6-K | 3 | Nov 20, 2024 |
6-k | Form 6-K | 3 | Oct 07, 2024 |
6-k | Form 6-K | 4 | Oct 03, 2024 |
6-k | Form 6-K | 5 | Sep 30, 2024 |
6-k/a | Form 6-K | 1 | Jun 24, 2024 |
6-k | Form 6-K | 1 | Jun 20, 2024 |
6-k | Form 6-K | 1 | May 24, 2024 |
6-k/a | Form 6-K | 2 | Apr 25, 2024 |
6-k | Form 6-K | 2 | Apr 24, 2024 |